NorthWest Biotherapeutics Inc (NWBO)

[FloatServe]

Agreed 100%. A HR of anything where the confidence intervals are below 1 would be statistically significant. A pvalue< 0.05 would be statistically significant

What’s also interesting to patients is long term survival odds, and dcvax will have that which no other therapy for GBM has in those regards. This would be clinically significant.

Safety is something that is incredibly important when considering a new therapy. This can not be understated. Well, we already know how the safety profile appears for dcvax, and that will play a huge role in the regulators decision making for approval

It’s almost permanent beach season, don’t forget to pack the sunscreen :)